AMYPAD Post-Doc Merle Hoenig presents at SNMMI confrerence
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting is recognised as the
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting is recognised as the
On 11 May, the members of the Amyloid Imaging to Prevent Alzheimer’s Disease (AMYPAD) project
On 1 April, the Amyloid imaging to prevent Alzheimer’s disease (AMYPAD) project held an online
A common sign of Alzheimer’s disease are deposits of a protein called beta amyloid. The
On 30 March, the Innovative Medicines Initiative (IMI) funded Neuronet Coordination and Support Action convened
The Neuronet programme launched a series of short introduction videos of the various Innovative Medicines
The AMYPAD consortium is pleased to announce its collaboration with the Alzheimer’s Disease Data Initiative
The collaboration within the AMYPAD consortium has been productive and efficient during the fifth year of the
Accurate regional brain quantitative PET measurements, particularly when using partial volume correction, rely on robust
The value of quantitative longitudinal and regional amyloid beta (Aβ) measurements in predicting cognitive decline